Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1491 Articles

Chris Lange | Jul 1, 2020 at 12:53 PM EDT

Meet the New Frontrunners in the Race for a COVID-19 Vaccine

Pfizer and BioNTech have been collaborating to produce a messenger RNA based vaccine for the past few months, and this…

Trey Thoelcke | Jun 25, 2020 at 6:15 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers still favored Exxon, Pfizer and Microsoft above all other Dow stocks.

Trey Thoelcke | Jun 10, 2020 at 6:55 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers still favored Exxon, Pfizer and Microsoft above all other Dow stocks.

Trey Thoelcke | May 28, 2020 at 7:20 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Exxon, Pfizer and Microsoft above all other Dow stocks.

Trey Thoelcke | May 12, 2020 at 7:05 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Exxon, Pfizer and Microsoft above all other Dow stocks. The…

Chris Lange | May 5, 2020 at 11:12 AM EDT

BioNTech and Pfizer Kick Off Human Trials for COVID-19 Vaccine

BioNTech and Pfizer stocks each made a handy gain on Monday after the companies announced the beginning of human trials…

Chris Lange | Apr 28, 2020 at 1:17 PM EDT

Why Pfizer and Merck Earnings Are Slowing the Dow

Merck and Pfizer reported their most recent quarterly results before the opening bell Tuesday. Although markets appear to be recovering,…

Chris Lange | Apr 27, 2020 at 12:13 PM EDT

What to Watch When Merck and Pfizer Report Tuesday Morning

Pharmaceutical giants Merck and Pfizer are expected to report their most recent quarterly results before the opening bell Tuesday.

Chris Lange | Apr 27, 2020 at 9:37 AM EDT

Big Pharma Short Sellers Can’t Make Up Their Minds

The April 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Trey Thoelcke | Apr 27, 2020 at 7:05 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Exxon, Microsoft and Pfizer above all other Dow stocks.

Chris Lange | Apr 26, 2020 at 7:20 AM EDT

Apple, Exxon, Microsoft, Pfizer and More Dow Earnings Coming This Week

Over one-third of the Dow Jones industrial average components are scheduled to report their latest quarterly reports this week. Here's…

Chris Lange | Apr 22, 2020 at 10:28 AM EDT

COVID-19 Vaccine Program on the Way in Germany

BioNTech shares shot up on Wednesday after the company announced, in conjunction with Pfizer, that its COVID-19 vaccine program was…

Chris Lange | Apr 13, 2020 at 9:58 AM EDT

Big Pharma Short Sellers Focus on a Couple of Favorites

The March 31 short interest data have been compared with the previous figures, and short interest moves in these selected…

Trey Thoelcke | Apr 13, 2020 at 7:05 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Exxon, Microsoft and Pfizer above all other Dow stocks. It…

Chris Lange | Apr 9, 2020 at 10:01 AM EDT

Will the Pfizer-BioNTech Collaboration Be a Winner in the Fight Against COVID-19?

Pfizer and BioNTech each saw gains on Thursday after the companies announced additional details regarding their collaboration in the fight…

1 … 22 23 24 25 26 … 100

Pfizer : PFE

All Pfizer Articles

Meet the New Frontrunners in the Race for a COVID-19 Vaccine

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

BioNTech and Pfizer Kick Off Human Trials for COVID-19 Vaccine

Why Pfizer and Merck Earnings Are Slowing the Dow

What to Watch When Merck and Pfizer Report Tuesday Morning

Big Pharma Short Sellers Can’t Make Up Their Minds

The 5 Most Shorted Dow Stocks

Apple, Exxon, Microsoft, Pfizer and More Dow Earnings Coming This Week

COVID-19 Vaccine Program on the Way in Germany

Big Pharma Short Sellers Focus on a Couple of Favorites

The 5 Most Shorted Dow Stocks

Will the Pfizer-BioNTech Collaboration Be a Winner in the Fight Against COVID-19?

Procter & Gamble vs. Colgate-Palmolive: One Dividend Giant Stands Above the Rest

Jim Cramer: CoreWeave’s Backlog ‘May Be Much Greater’ Than Wall Street Thinks

Google, SpaceX, Microsoft, and Amazon Are About to Spend ‘Twice the Entire U.S. Defense Budget’ on AI

SECURE 2.0 Changes Force High Earners to Rethink 401(k) Strategy. Here's the Math.

The RFK Jr. Medicare AI Program Already Denying Seniors Care in 6 States

Procter & Gamble vs. Colgate-Palmolive: One Dividend Giant Stands Above the Rest

Jim Cramer: CoreWeave’s Backlog ‘May Be Much Greater’ Than Wall Street Thinks

Pfizer : PFE

All Pfizer Articles

Meet the New Frontrunners in the Race for a COVID-19 Vaccine

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

BioNTech and Pfizer Kick Off Human Trials for COVID-19 Vaccine

Why Pfizer and Merck Earnings Are Slowing the Dow

What to Watch When Merck and Pfizer Report Tuesday Morning

Big Pharma Short Sellers Can’t Make Up Their Minds

The 5 Most Shorted Dow Stocks

Apple, Exxon, Microsoft, Pfizer and More Dow Earnings Coming This Week

COVID-19 Vaccine Program on the Way in Germany

Big Pharma Short Sellers Focus on a Couple of Favorites

The 5 Most Shorted Dow Stocks

Will the Pfizer-BioNTech Collaboration Be a Winner in the Fight Against COVID-19?

Procter & Gamble vs. Colgate-Palmolive: One Dividend Giant Stands Above the Rest

Jim Cramer: CoreWeave’s Backlog ‘May Be Much Greater’ Than Wall Street Thinks

Google, SpaceX, Microsoft, and Amazon Are About to Spend ‘Twice the Entire U.S. Defense Budget’ on AI

Featured Reads

SECURE 2.0 Changes Force High Earners to Rethink 401(k) Strategy. Here's the Math.

The RFK Jr. Medicare AI Program Already Denying Seniors Care in 6 States